Written question asked by Lord Goodlad (Conservative) on Wednesday, 7 December 2022, in the House of Lords. It was due for an answer on Wednesday, 21 December 2022. It was answered by Lord Markham (Conservative) on Wednesday, 14 December 2022 on behalf of the Department of Health and Social Care.
Lecanemab
- Question
-
To ask His Majesty's Government what discussions they have had about improving dementia diagnosis to prepare for the arrival of Lecanemab.
- Answer
-
We have had no specific discussions. NHS England continuously reviews potentially promising new medicines which might provide benefits to patients in future, including Lecanemab.
Secondary information
- Type
- Written question
- Reference
- HL4096
- Session
- 2022-23
- Subjects
- Dementia Diagnosis Lecanemab
- Link
- View this Written question on www.parliament.uk
Librarians' tools
- Timestamp
- 2022-12-14 12:37:46 +0000
- URI
- http://data.parliament.uk/writtenparliamentaryquestion/lords/2022-23/HL4096
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/writtenparliamentaryquestion/lords/2022-23/HL4096
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/writtenparliamentaryquestion/lords/2022-23/HL4096